This week, the Ohio House passed House Bill 324, “The Patient Protection Act,” by a vote of 59 to 28. This bill is intended to restrict mail-order sales of certain medications with severe adverse effects in more than 5% of their users, including Mifepristone and other abortion drugs. For example, Mifepristone would be classified as a dangerous drug, meaning a woman would be required to make an in-person visit to her doctor and be informed o f the harmful side effects before t

Last Wednesday, the Ohio Department of Health released Ohio’s 2024 genocide report . The only good news in all of this is that 171 fewer...

Last month Nancy Dollard wrote an article in the Blade spreading lies about crisis pregnancy centers (CPCs). She claims that CPCs do not...

Yesterday the Ohio Department of Health (ODOH) released the 2023 abortion statistics report that showed a significant increase in the...